InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Last Andrew J., 首席运营官. Insider active across 5 companies, notably OncoCyte Corp. Cumulatively, 19 reports have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €908k. History available since 11 June 2021. The latest transaction was filed on 1 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Last Andrew J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
7,700 股@ US$5.69100.0% 占其流量Common Stock, no par valueSEC:0001493152-26-032233:0
35,000 股0Common Stock, no par valueSEC:0001641172-25-017787:0
3,000 股@ US$299.2428.8% 占其流量Bio-Rad A Common StockSEC:0001062993-24-016386:0
3,000 股@ US$329.938431.8% 占其流量Bio-Rad A Common StockSEC:0001062993-24-016386:1
1,252 股0Bio-Rad A Common StockSEC:0001062993-24-016169:0
357 股@ US$277.113.3% 占其流量Bio-Rad A Common StockSEC:0001062993-24-009082:1
1,000 股0Bio-Rad A Common StockSEC:0001062993-24-009082:0
867 股0Bio-Rad A Common StockSEC:0001062993-23-017654:0
20,000 股0Common Stock, no par valueSEC:0001493152-23-022669:0
1,000 股0Bio-Rad A Common StockSEC:0001062993-23-009749:0
902 股0Bio-Rad A Common StockSEC:0001062993-22-019282:0
633 股0Bio-Rad A Common StockSEC:0001062993-22-019194:0
20,000 股@ US$0.8733.1% 占其流量Common Stock, no par valueSEC:0001493152-22-023524:0
标准退出：2022年11月15日 (T+90)
10,000 股0Common Stock, no par valueSEC:0001493152-22-023385:0
10,000 股0Common Stock, no par valueSEC:0001493152-22-019822:0
1,000 股0Bio-Rad A Common StockSEC:0001062993-22-011169:0
2,000 股@ US$299.2422.0% 占其流量Bio-Rad A Common StockSEC:0001062993-21-008244:0
6,993 股@ US$3.0050.2% 占其流量Common StockSEC:0001493152-21-014342:0
37,297 股Common StockSEC:0001140361-16-051546:0
19 条申报中的 19 条
About Last Andrew J.
Last Andrew J. is Director of Operations. He has 19 filings in total, and across the recent sample of 19 filings, the reported cumulative amounts are EUR 17,092 of buys and EUR 890,834 of sells, with activity ranging from 2016-02-10 to 2026-07-06. The most common transaction nature is Option exercise, and the companies listed are Bio-Rad Laboratories, INC., OncoCyte Corp, Insight Molecular Diagnostics Inc., and AFFYMETRIX INC.
